Searchable abstracts of presentations at key conferences in endocrinology

ea0029p367 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Rhabdomyolysis and myopathy in Addison’s disease: is there a connection?

Katalinic D. , Solter M. , Planinc D. , Plestina S.

Introduction: Rhabdomyolysis coexisting with Addison’s disease is a rare condition and the mechanism is not clearly defined. We report a patient presenting with sever rhabdomyolysis which resolved after steroid replacement therapy.Case report: A 33-year-old man without accompanying comorbidity, presented with progressive myopathy and fatigue. He was hypotensive (RR 90/70), hypovolemic with hyponatremia (125 mmol/l, range 137–146), elevated seru...

ea0029p869 | Endocrine tumours and neoplasia | ICEECE2012

Antiproliferative effect and control of catecholamine release with octreotide in a patient with giant bilateral pheochromocytoma

Katalinic D. , Plestina S. , Vrkljan M. , Aleric I. , Maric A.

Introduction: Pheochromocytomas are rare but treacherous catecholamine-producing tumors of the medulla of the adrenal glands (originating in the chromaffin cells), or extra-adrenal chromaffin tissue. We refer a case with stabilization of tumor growth and hormonal improvements following repeated s.c. injections of octreotide.Case report: We report a female patient aged 35 with a finding of bilateral adrenal mass with sever cardiovascular symptomatology (f...

ea0026p722 | Diabetes (epidemiology, pathophysiology) | ECE2011

Impact of INSR His1085 and IRS1 Gly972Arg genetic variability on dyslipidaemia in patients with metabolic syndrome and type 2 diabetes

Katalinic D , Nikolac N , Zjacic-Rotkvic V , Solter M , Topic E , Vrkljan M , Plestina S

Introduction: The metabolic syndrome is increasingly recognized as a powerful predictor of patient risk for developing cardiovascular and cerebrovascular complications. It is viewed as the phenotypic confluence of atherogenic dyslipidaemia, hypertension, central obesity and insulin resistance (with or without type 2 diabetes) resulting from dysregulated gene expression and lifestyle behaviours.Aim: Because insulin resistance is a core defect in type 2 di...